Lifeward

Lifeward EBITDA

The EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Lifeward (LFWD) as of Oct 8, 2026 is -19.53 M USD. In the previous year, EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) was -19.55 M USD — a change of -0.11% (higher).

EBITDA

-19.53 MUSD

YoY

-0.11%

Last updated:

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Lifeward is 2025 -19.53 M USD. EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Lifeward was 2024 -19.55 M USD. It decreases by -0.11% higher compared to the previous year.

The Lifeward EBITDA history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA
Date
EBITDA
Jan 1, 2018
-19.21 M USD
Jan 1, 2019
-14.05 M USD
Jan 1, 2020
-12.02 M USD
Jan 1, 2021
-12.66 M USD
Jan 1, 2022
-19.10 M USD
Jan 1, 2023
-23.61 M USD
Jan 1, 2024
-19.55 M USD
Jan 1, 2025
-19.53 M USD
The Lifeward EBITDA history
YEAREBITDAYoY
-19.53 MUSD-0.11%
-19.55 MUSD-17.19%
-23.61 MUSD+23.61%
-19.10 MUSD+50.94%
-12.66 MUSD+5.30%
-12.02 MUSD-14.45%
-14.05 MUSD-26.89%
-19.21 MUSD-12.63%
-21.99 MUSD-27.76%
-30.44 MUSD+20.92%
-25.17 MUSD+26.34%
-19.93 MUSD—
Access this data via the Eulerpool API

Lifeward Stock analysis

What does Lifeward do? Rewalk Robotics Ltd is a publicly traded company specializing in the development and manufacture of exoskeletons that enable individuals with spinal injuries or paralysis to regain mobility. It was founded in 2001 and is based in Marlborough, Massachusetts. The company's goal is to provide individuals with mobility impairments the opportunity for greater freedom of movement and improved quality of life. Rewalk Robotics has launched various products in the field of rehabilitation and industrial applications, and it continues to research and develop new applications for its technology. The exoskeletons use a combination of motors, sensors, and control systems to allow users to stand, walk, and even climb stairs. In addition to medical applications, Rewalk Robotics also provides exoskeletons for industrial use, enhancing worker safety and productivity. The company is actively involved in research and development to expand the therapeutic possibilities of exoskeletons for neurologic conditions such as stroke and Parkinson's disease. Rewalk Robotics is dedicated to innovation and technology, aiming to improve the lives of millions worldwide by providing greater mobility and autonomy. Lifeward is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Lifeward stock

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Lifeward is -19.53 M USD in 2025.

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Lifeward changed from -19.55 M USD to -19.53 M USD, representing a -0.11% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) Lifeward since 2006 – with annual values, charts, and detailed analysis.

EBITDA measures operating performance before the impact of financial structure, tax environment, and non-cash depreciation charges.

EBITDA = EBIT + Depreciation & Amortization

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization)'s USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization)'s Lifeward historically and in real time.

Access this data via the Eulerpool API

Income Statement — Lifeward

All Key Metrics — Lifeward